Adaptimmune Therapeutics plc logo
Adaptimmune Therapeutics plc ADAP

Quartalsbericht 2025-Q2
hinzugefügt 13.08.2025

report update icon

Adaptimmune Therapeutics plc DSO 2011-2025 | ADAP

DSO Jährlich Adaptimmune Therapeutics plc

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
25 55 26.4 6.41 6.72 K 111 1.99 38 185 - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
6.72 K 1.99 797

DSO Vierteljährlich Adaptimmune Therapeutics plc

2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
45.7 36.5 - 16.6 3.82 74.1 - 23.4 41.7 8.77 - 11.6 15 32.9 - 144 31.8 14.6 - 10.6 12.6 - - 733 1.11 K - - 0.43 1.94 2.22 - 0.69 5.34 26.9 - 55.9 206 11.7 - 13.7 24.4 3.78 - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
1.11 K 0.43 90.6

DSO anderer Aktien in der Pharmaeinzelhändler

Name DSO Preis % 24h Marktkapitalisierung Land
Alpine Immune Sciences Alpine Immune Sciences
ALPN
154 - - $ 2.17 B usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
31.5 $ 4.67 - $ 775 M canadaCanada
Aclaris Therapeutics Aclaris Therapeutics
ACRS
6.01 $ 3.36 - $ 260 M usaUSA
Acasti Pharma Acasti Pharma
ACST
1.97 - 4.01 % $ 150 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
132 $ 210.16 - $ 5 B danmarkDanmark
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
Albireo Pharma Albireo Pharma
ALBO
14.7 - -0.23 % $ 916 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
Aptorum Group Limited Aptorum Group Limited
APM
20.6 $ 1.33 - $ 7.25 M chinaChina
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
16.2 K $ 3.42 - $ 8.23 B australiaAustralia
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
62.6 $ 25.9 - $ 1.25 B usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
77.3 $ 9.49 - $ 139 M usaUSA
Brickell Biotech Brickell Biotech
BBI
254 - -5.38 % $ 6.06 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
49.5 - 0.49 % $ 251 B cayman-islandsCayman-islands
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
6.09 - -9.72 % $ 5.89 M usaUSA
Berkeley Lights Berkeley Lights
BLI
103 - -7.31 % $ 87 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
150 $ 2.28 - $ 14.3 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
946 - -6.81 % $ 3.04 B usaUSA
Biogen Biogen
BIIB
57.9 $ 172.5 - $ 25.1 B usaUSA
Baudax Bio Baudax Bio
BXRX
126 - 0.59 % $ 63 K usaUSA
ChromaDex Corporation ChromaDex Corporation
CDXC
13.2 - -0.88 % $ 598 M usaUSA
Axon Enterprise Axon Enterprise
AXON
134 $ 581.03 - $ 44 B usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
6.83 - - $ 169 M usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
164 - -16.75 % $ 25.8 M usaUSA
Clovis Oncology Clovis Oncology
CLVS
65.5 - -7.23 % $ 13 M usaUSA
Benitec Biopharma Benitec Biopharma
BNTC
141 $ 12.96 1.17 % $ 533 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
60.8 - - $ 2.18 B usaUSA
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
169 $ 11.44 - $ 740 M usaUSA
Eloxx Pharmaceuticals Eloxx Pharmaceuticals
ELOX
157 - -5.68 % $ 8.28 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
28.1 $ 0.29 -0.31 % $ 631 M israelIsrael
Catalyst Biosciences Catalyst Biosciences
CBIO
3.24 $ 15.31 - $ 1.01 B usaUSA
Epizyme Epizyme
EPZM
47.2 - - $ 249 M usaUSA
Cerus Corporation Cerus Corporation
CERS
59.2 $ 2.15 - $ 397 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
48.3 - -24.86 % $ 820 K usaUSA